Noxilizer Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $30M

  • Investors
  • 2

Noxilizer General Information

Description

Developer of nitrogen dioxide sterilization technology designed to facilitate pharmaceutical and biotech manufacturing. The company's technology utilizes ultra-low temperature processing, low-pressure mechanisms, and rapid cycle times to provide terminal sterilization, material compatibility, and protein integrity preservation, enabling pharmaceutical and medical device manufacturers to protect temperature-sensitive drug-device combination products and accelerate batch release timelines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1334 Ashton Road
  • Suite E
  • Hanover, MD 21076
  • United States
+1 (443)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Laboratory Services (Healthcare)
Medical Supplies
Corporate Office
  • 1334 Ashton Road
  • Suite E
  • Hanover, MD 21076
  • United States
+1 (443)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noxilizer Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 10-Sep-2025 $30M Completed Generating Revenue
13. Secondary Transaction - Private 01-Sep-2022 Completed Generating Revenue
12. Secondary Transaction - Private 01-Mar-2021 Completed Generating Revenue
11. Debt - PPP 11-Apr-2020 Completed Generating Revenue
10. Later Stage VC 03-Apr-2014 Completed Generating Revenue
9. Later Stage VC (Series C) 03-Sep-2013 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
7. Later Stage VC (Series B) 21-Nov-2012 Completed Generating Revenue
6. Grant 07-Sep-2012 $500K $18.2M Completed Generating Revenue
5. Later Stage VC 22-Oct-2010 $5.67M $18.2M Completed Generating Revenue
To view Noxilizer’s complete valuation and funding history, request access »

Noxilizer Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C3
Series C2
Series C1
Series B4
Series B3
Series B2
Series B1 11,200,000 $0.010000 8% $0.63 $1.26 $0.63 22.32%
Series A 11,000,000 $0.010000 6% $0.72 $0.72 $0.72 21.93%
To view Noxilizer’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Noxilizer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nitrogen dioxide sterilization technology designed to facilitate pharmaceutical and biotech manufacturing.
Other Pharmaceuticals and Biotechnology
Hanover, MD
42 As of 2025

Rio de Janeiro, Brazil

Franklin Lakes, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noxilizer Competitors (11)

One of Noxilizer’s 11 competitors is Hartmann (Medical Supplies), a Corporation company based in Rio de Janeiro, Brazil.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hartmann (Medical Supplies) Corporation Rio de Janeiro, Brazil
Becton, Dickinson and Company Corporation Franklin Lakes, NJ
Wassenburg Medical Corporate Backed or Acquired Elst, Netherlands
Sotera Health Formerly PE-Backed Broadview Heights, OH
Steelco Corporate Backed or Acquired Riese Pio X, Italy
You’re viewing 5 of 11 competitors. Get the full list »

Noxilizer Patents

Noxilizer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260083871-A1 Sterilization methods Pending 24-Sep-2024
WO-2026072672-A1 Sterilization methods Pending 24-Sep-2024
US-20260085269-A1 Sterilization process challenge devices Pending 24-Sep-2024
WO-2026072720-A1 Sterilization process challenge devices Pending 24-Sep-2024
US-12708681-B2 Method of sterilization specimen conditioning Active 14-Jun-2022 A61L2/06
To view Noxilizer’s complete patent history, request access »

Noxilizer Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noxilizer Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
NewVale Capital Growth/Expansion Minority
VisionTech Partners Angel Group Minority
To view Noxilizer’s complete investors history, request access »

Noxilizer Acquisitions (1)

Noxilizer’s most recent deal was a Merger/Acquisition with SAIAN. The deal was made on 01-Feb-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SAIAN 01-Feb-2013 Merger/Acquisition Other Devices and Supplies
To view Noxilizer’s complete acquisitions history, request access »

Noxilizer FAQs

  • When was Noxilizer founded?

    Noxilizer was founded in 2004.

  • Where is Noxilizer headquartered?

    Noxilizer is headquartered in Hanover, MD.

  • What is the size of Noxilizer?

    Noxilizer has 42 total employees.

  • What industry is Noxilizer in?

    Noxilizer’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Noxilizer a private or public company?

    Noxilizer is a Private company.

  • What is Noxilizer’s current revenue?

    The current revenue for Noxilizer is .

  • How much funding has Noxilizer raised over time?

    Noxilizer has raised $61.5M.

  • Who are Noxilizer’s investors?

    NewVale Capital and VisionTech Partners have invested in Noxilizer.

  • Who are Noxilizer’s competitors?

    Hartmann (Medical Supplies), Becton, Dickinson and Company, Wassenburg Medical, Sotera Health, and Steelco are some of the 11 competitors of Noxilizer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process